Global Animal Blood Plasma and Derivatives Market Growth (Status and Outlook) 2022-2028

Global Animal Blood Plasma and Derivatives Market Growth (Status and Outlook) 2022-2028

Product Code:214771

Published Date: Jan 13,2022

Pages: 101

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

As the global economy mends, the 2021 growth of Animal Blood Plasma and Derivatives will have significant change from previous year. According to our (LP Information) latest study, the global Animal Blood Plasma and Derivatives market size is USD  million in 2022 from USD 976.6 million in 2021, with a change of  % between 2021 and 2022. The global Animal Blood Plasma and Derivatives market size will reach USD 1344.1 million in 2028, growing at a CAGR of 4.7% over the analysis period.

The United States Animal Blood Plasma and Derivatives market is expected at value of US$  million in 2021 and grow at approximately  % CAGR during review period. China constitutes a  % market for the global Animal Blood Plasma and Derivatives market, reaching US$  million by the year 2028. As for the Europe Animal Blood Plasma and Derivatives landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at  % and  % respectively for the next 5-year period.

Global main Animal Blood Plasma and Derivatives players cover Proliant Inc., Thermo Fisher Scientific, Inc., Merck KGaA, and Kraeber & Co GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly  % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal Blood Plasma and Derivatives market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
    Immunoglobulin
    Fibrinogen
    Serum Albumin
    Fetal Bovine Serum
    Thrombin
    New Born Calf Serum

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
    Food & Beverages
    Pharmaceuticals
    Cosmetics
    Feed
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Proliant Inc.
    Thermo Fisher Scientific, Inc.
    Merck KGaA
    Kraeber & Co GmbH
    LAMPIRE Biological Laboratories, Inc.
    Lake Immunogenics, Inc.
    Rocky Mountain Biologicals Inc.
    ANZCO Foods Ltd.
    Auckland BioSciences Ltd.
    Bovogen Biologicals Pty Ltd.